Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

GLP1-INT reverses hyperglycemia and evokes B-cell regeneration in vivo

June 29, 2005

Phase IIb study investigates APD-356 for obesity

June 29, 2005

Neose files IND for NE-180 for chemotherapy-induced anemia

June 29, 2005

Metabasis and Merck collaborate in type 2 diabetes, hyperlipidemia and obesity

June 29, 2005

Cholesterol-lowering drug FM-VP4 completes 90-day toxicity study

June 29, 2005

E1-INT studied in type 1 diabetics

June 29, 2005

Novel PYY analogues CJC-1682 and CJC-1643 reduce food intake in rats

June 29, 2005

Early studies reveal clinical activity of SOM-230

June 29, 2005

Once-monthly Bonviva receives recommendation from European CHMP

June 28, 2005

Preclinical studies characterize the activity of oleoyl estrone

June 28, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...